Real-time enrollment status for this relapsed/refractory (r/r) mature b cell non hodgkin lymphoma (nhl) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:51 AM UTC
| NCT Number | NCT06393738 |
| Recruiting Status | Recruiting |
| Condition | Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL) |
| Phase | Clinical Trial |
| Target Enrollment | 255 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Arvinas Inc. |
| Last Updated on CT.gov | February 10, 2026 (Feb 10, 2026) |
As of July 13, 2026: Clinical trial NCT06393738 is currently recruiting participants. This clinical trial study for relapsed/refractory (r/r) mature b cell non hodgkin lymphoma (nhl) is actively seeking new participants at 8 locations across the United States. The study is sponsored by Arvinas Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06393738 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06393738 was last updated Feb 10, 2026 (February 10, 2026). HelloStudys verifies this status automatically.